Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02929576
Title Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer (ENDEAR)
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors Medivation, Inc.
Indications

triple-receptor negative breast cancer

Therapies

Paclitaxel

Enzalutamide + Paclitaxel

Enzalutamide

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Topeka Kansas 66606 United States Details
Metairie Louisiana 70006 United States Details
Bronx New York 10469 United States Details
Houston Texas 77030 United States Details
Tacoma Washington 98405 United States Details
Wenatchee Washington 98801 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field